| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 11010986 | Clinical Biochemistry | 2018 | 29 Pages |
Abstract
Given these data, we conclude that IDH1/2 mutations can be used as a reliable and cost-effective marker for MRD monitoring.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Lucie Petrova, Filip Vrbacky, Miriam Lanska, Alzbeta Zavrelova, Pavel Zak, Katerina Hrochova,